Literature DB >> 22245975

The impact of general versus local anesthesia on early subclinical cognitive function following carotid endarterectomy evaluated using P3 event-related potentials.

Jan Mracek1, Irena Holeckova, Ivan Chytra, Jan Mork, David Stepanek, Petra Vesela.   

Abstract

BACKGROUND: Postoperative cognitive dysfunction (POCD) is detected in 25% of patients undergoing carotid endarterectomy (CEA). The mechanism of POCD is poorly understood, but it is believed that general anesthesia (GA) itself may contribute significantly to POCD. The aim of our prospective study was to compare, with the aid of event-related potentials, the impact of general anesthesia (GA) and local anesthesia (LA) on POCD in patients undergoing CEA.
METHODS: Sixty patients were included in this study and were divided into two groups: CEA was performed in 30 patients placed under GA (total intravenous anesthesia), herein the GA group, while 30 patients underwent CEA under LA (cervical plexus block), herein LA group. Cognitive outcome was assessed with the use of auditory event-related potentials (ERPs), P3 response. The measurements were taken before surgery (pre-op) and on the first (1.post-op) and the sixth postoperative days (6.post-op).
RESULTS: Preoperative cognitive functions did not differ significantly between the two groups. A significant decrease in P3 amplitude was found on the first postoperative day (1.post-op) in the GA group (p = 0.0005), but normalization of P3 amplitude was detected at the second postoperative measurement (6.post-op). The patients operated on under local anesthesia (LA group) showed stable P3 amplitudes in all three measurements. No significant changes in P3 latencies were observed in either group. There were no significant differences between the two groups regarding demographic characteristics, preoperative and postoperative clinical condition, percentage significance of carotid artery stenosis, duration of carotid cross-clamping or in the frequency of shunt use (zero frequency for both groups).
CONCLUSIONS: Our study showed that general anesthesia, used for patients undergoing CEA, negatively influenced cognitive function during the immediate period after surgery (the first postoperative day). However, by the sixth postoperative day, this cognitive impairment was no longer being detected. POCD occurring shortly after carotid endarterectomy is the result of general anesthesia, which is probably an independent evoking factor in itself. The cognitive deficit recorded only during the immediate postoperative period, is not a negative effect of GA but merely a side-effect and thus GA should not be considered inferior to LA for use during CEA.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22245975     DOI: 10.1007/s00701-011-1270-4

Source DB:  PubMed          Journal:  Acta Neurochir (Wien)        ISSN: 0001-6268            Impact factor:   2.216


  5 in total

Review 1.  Practical Regional Anesthesia Guide for Elderly Patients.

Authors:  Carole Lin; Curtis Darling; Ban C H Tsui
Journal:  Drugs Aging       Date:  2019-03       Impact factor: 3.923

2.  Propofol versus sevoflurane anaesthesia: effect on cognitive decline and event-related potentials.

Authors:  Jakub Kletecka; Irena Holeckova; Pavel Brenkus; Jiri Pouska; Jan Benes; Ivan Chytra
Journal:  J Clin Monit Comput       Date:  2018-10-31       Impact factor: 2.502

Review 3.  Neurocognitive functioning after carotid revascularization: a systematic review.

Authors:  Maarten Plessers; Isabelle Van Herzeele; Frank Vermassen; Guy Vingerhoets
Journal:  Cerebrovasc Dis Extra       Date:  2014-06-24

Review 4.  Cognitive function and carotid stenosis: Review of the literature.

Authors:  Aurélio Pimenta Dutra
Journal:  Dement Neuropsychol       Date:  2012 Jul-Sep

5.  Cancer-Related Anemia Is a Risk Factor for Medium-Term Postoperative Cognitive Dysfunction in Laparoscopic Surgery Patients: An Observational Prospective Study.

Authors:  Huimei Huang; Fei Lin; Liming Cen; Ren Jing; Linghui Pan
Journal:  Neural Plast       Date:  2020-02-06       Impact factor: 3.599

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.